Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Resolved | 2017-04-10 | 2018-05-05 | 6298 |
| PMS-RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Resolved | 2017-04-10 | 2019-07-11 | 6309 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Resolved | 2018-01-03 | 2018-01-17 | 34875 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Resolved | 2019-01-23 | 2019-04-11 | 73343 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80811 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147790 |
| MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2017-05-26 | 2017-09-02 | 11351 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2017-10-20 | 2018-03-17 | 26483 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2018-05-11 | 2018-06-09 | 49074 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |